Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Oct;24(4):500–504. doi: 10.1128/aac.24.4.500

Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections.

J D Blanco, R S Gibbs, P Duff, Y S Castaneda, P J St Clair
PMCID: PMC185362  PMID: 6360038

Abstract

A randomized comparison of ceftazidime versus clindamycin-tobramycin was performed for the treatment of obstetrical and gynecological infections. Entry criteria were an oral temperature of greater than or equal to 38 degrees C and a clinical diagnosis of endometritis, salpingitis, or pelvic cellulitis after hysterectomy. All patients with endometritis had cultures of intrauterine material obtained via a transcervical single-lumen catheter. The patients with pelvic cellulitis had material from the vaginal apex aspirated for culture, and all patients with salpingitis had a culdocentesis for culture of intraperitoneal material. Of 38 patients who received ceftazidime, 34 had endometritis after cesarean section, 3 had endometritis after abortion, and 1 had pelvic cellulitis. Of 39 patients who received clindamycin-tobramycin, 35 had endometritis after cesarean section, 3 had salpingitis, and 1 had pelvic cellulitis. The most common bacterial isolates were Lactobacillus sp., Bacteroides bivius, Escherichia coli, other gram-negative aerobic bacilli, group B streptococci, and other aerobic streptococci. Bacteremia occurred in 9.0% of the patients. Of the patients receiving clindamycin-tobramycin and ceftazidime, 34 (87.2%) and 34 (89.5%), respectively, responded to therapy. All the clinical failures occurred in patients with endometritis after cesarean section. Clinical failures had persistent fever despite 3 or more days of treatment. One of the patients receiving clindamycin-tobramycin developed an urticarial rash after her infection had resolved. No patient in either group developed diarrhea. In these small groups of patients, there were no significant differences in cure rate, side effects, or length of hospital stay.

Full text

PDF
500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Duff P., Gibbs R. S., Blanco J. D., St Clair P. J. Endometrial culture techniques in puerperal patients. Obstet Gynecol. 1983 Feb;61(2):217–222. [PubMed] [Google Scholar]
  2. Gibbs R. S., Blanco J. D., Castaneda Y. S., St Clair P. J. A double-blind, randomized comparison of clindamycin-gentamicin versus cefamandole for treatment of post-cesarean section endomyometritis. Am J Obstet Gynecol. 1982 Oct 1;144(3):261–267. doi: 10.1016/0002-9378(82)90576-2. [DOI] [PubMed] [Google Scholar]
  3. Gibbs R. S., Blanco J. D., Castaneda Y. S., St Clair P. J. Therapy of obstetrical infections with moxalactam. Antimicrob Agents Chemother. 1980 Jun;17(6):1004–1007. doi: 10.1128/aac.17.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gibbs R. S., Blanco J. D., Duff P., Castaneda Y. S., St Clair P. J. A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery. Am J Obstet Gynecol. 1983 Aug 1;146(7):769–772. doi: 10.1016/0002-9378(83)91075-x. [DOI] [PubMed] [Google Scholar]
  5. Gibbs R. S., Huff R. W. Cefamandole therapy of endomyometritis following cesarean section. Am J Obstet Gynecol. 1980 Jan 1;136(1):32–37. doi: 10.1016/0002-9378(80)90560-8. [DOI] [PubMed] [Google Scholar]
  6. Gibbs R. S., Jones P. M., Wilder C. J. Antibiotic therapy of endometritis following cesarean section. Treatment successes and failures. Obstet Gynecol. 1978 Jul;52(1):31–37. [PubMed] [Google Scholar]
  7. Neu H. C., Labthavikul P. Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1982 Jan;21(1):11–18. doi: 10.1128/aac.21.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sweet R. L., Ledger W. J. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections. Obstet Gynecol. 1979 Aug;54(2):193–198. [PubMed] [Google Scholar]
  9. Tanphaichitra D., Bussayanond A., Christensen O. The combination of pivmecillinam and pivampicillin in the treatment of acute enteric fever. J Antimicrob Chemother. 1981 Jul;8(1):23–28. doi: 10.1093/jac/8.1.23. [DOI] [PubMed] [Google Scholar]
  10. Weinstein W. M., Onderdonk A. B., Bartlett J. G., Gorbach S. L. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun. 1974 Dec;10(6):1250–1255. doi: 10.1128/iai.10.6.1250-1255.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Zaske D. E., Cipolle R. J., Strate R. G., Malo J. W., Koszalka M. F., Jr Rapid gentamicin elimination in obstetric patients. Obstet Gynecol. 1980 Nov;56(5):559–564. [PubMed] [Google Scholar]
  12. diZerega G., Yonekura L., Roy S., Nakamura R. M., Ledger W. J. A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of post-cesarean section endomyometritis. Am J Obstet Gynecol. 1979 Jun 1;134(3):238–242. doi: 10.1016/s0002-9378(16)33026-5. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES